BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mustafa S, See HB, Seeber RM, Armstrong SP, White CW, Ventura S, Ayoub MA, Pfleger KD. Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromer. J Biol Chem 2012;287:12952-65. [PMID: 22371491 DOI: 10.1074/jbc.M111.322834] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Evans AE, Tripathi A, LaPorte HM, Brueggemann LI, Singh AK, Albee LJ, Byron KL, Tarasova NI, Volkman BF, Cho TY, Gaponenko V, Majetschak M. New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle. Int J Mol Sci 2016;17:E971. [PMID: 27331810 DOI: 10.3390/ijms17060971] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
2 Enten GA, Gao X, Strzelinski HR, Weche M, Liggett SB, Majetschak M. α1B/D-adrenoceptors regulate chemokine receptor-mediated leukocyte migration via formation of heteromeric receptor complexes. Proc Natl Acad Sci U S A 2022;119:e2123511119. [PMID: 35537053 DOI: 10.1073/pnas.2123511119] [Reference Citation Analysis]
3 White CW, da Silva Junior ED, Lim L, Ventura S. What makes the α1A -adrenoceptor gene product assume an α1L -adrenoceptor phenotype? Br J Pharmacol 2019;176:2358-65. [PMID: 30719698 DOI: 10.1111/bph.14599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Stone MJ, Hayward JA, Huang C, E Huma Z, Sanchez J. Mechanisms of Regulation of the Chemokine-Receptor Network. Int J Mol Sci 2017;18:E342. [PMID: 28178200 DOI: 10.3390/ijms18020342] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 20.6] [Reference Citation Analysis]
5 Karcz TP, Whitehead GS, Nakano K, Nakano H, Grimm SA, Williams JG, Deterding LJ, Jacobson KA, Cook DN. UDP-glucose and P2Y14 receptor amplify allergen-induced airway eosinophilia. J Clin Invest 2021;131:140709. [PMID: 33792561 DOI: 10.1172/JCI140709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Jaeger WC, Seeber RM, Eidne KA, Pfleger KD. Molecular determinants of orexin receptor-arrestin-ubiquitin complex formation. Br J Pharmacol 2014;171:364-74. [PMID: 24206104 DOI: 10.1111/bph.12481] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
7 Ayoub MA, Zhang Y, Kelly RS, See HB, Johnstone EK, McCall EA, Williams JH, Kelly DJ, Pfleger KD. Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease. PLoS One 2015;10:e0119803. [PMID: 25807547 DOI: 10.1371/journal.pone.0119803] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
8 Johnstone EK, Pfleger KD. Receptor-Heteromer Investigation Technology and its application using BRET. Front Endocrinol (Lausanne) 2012;3:101. [PMID: 22936924 DOI: 10.3389/fendo.2012.00101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
9 Jaeger WC, Armstrong SP, Hill SJ, Pfleger KD. Biophysical Detection of Diversity and Bias in GPCR Function. Front Endocrinol (Lausanne) 2014;5:26. [PMID: 24634666 DOI: 10.3389/fendo.2014.00026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
10 Johnstone EKM, Pfleger KDG. Profiling novel pharmacology of receptor complexes using Receptor-HIT. Biochem Soc Trans 2021;49:1555-65. [PMID: 34436548 DOI: 10.1042/BST20201110] [Reference Citation Analysis]
11 Bach HH 4th, Wong YM, Tripathi A, Nevins AM, Gamelli RL, Volkman BF, Byron KL, Majetschak M. Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function. Mol Med 2014;20:435-47. [PMID: 25032954 DOI: 10.2119/molmed.2014.00101] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
12 Felce JH, MacRae A, Davis SJ. Constraints on GPCR Heterodimerization Revealed by the Type-4 Induced-Association BRET Assay. Biophys J 2019;116:31-41. [PMID: 30558888 DOI: 10.1016/j.bpj.2018.09.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
13 Myagmar BE, Ismaili T, Swigart PM, Raghunathan A, Baker AJ, Sahdeo S, Blevitt JM, Milla ME, Simpson PC. Coupling to Gq Signaling Is Required for Cardioprotection by an Alpha-1A-Adrenergic Receptor Agonist. Circ Res 2019;125:699-706. [PMID: 31426700 DOI: 10.1161/CIRCRESAHA.118.314416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
14 Ayoub MA, See HB, Seeber RM, Armstrong SP, Pfleger KD. Profiling epidermal growth factor receptor and heregulin receptor 3 heteromerization using receptor tyrosine kinase heteromer investigation technology. PLoS One 2013;8:e64672. [PMID: 23700486 DOI: 10.1371/journal.pone.0064672] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
15 Sampaio NG, Kocan M, Schofield L, Pfleger KDG, Eriksson EM. Investigation of interactions between TLR2, MyD88 and TIRAP by bioluminescence resonance energy transfer is hampered by artefacts of protein overexpression. PLoS One 2018;13:e0202408. [PMID: 30138457 DOI: 10.1371/journal.pone.0202408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
16 Armstrong SP, Seeber RM, Ayoub MA, Feldman BJ, Pfleger KD. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V). PLoS One 2013;8:e65885. [PMID: 23762448 DOI: 10.1371/journal.pone.0065885] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
17 Watts AO, van Lipzig MM, Jaeger WC, Seeber RM, van Zwam M, Vinet J, van der Lee MM, Siderius M, Zaman GJ, Boddeke HW, Smit MJ, Pfleger KD, Leurs R, Vischer HF. Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes. Br J Pharmacol 2013;168:1662-74. [PMID: 23170857 DOI: 10.1111/bph.12064] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
18 Tóth AD, Prokop S, Gyombolai P, Várnai P, Balla A, Gurevich VV, Hunyady L, Turu G. Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins. J Biol Chem 2018;293:876-92. [PMID: 29146594 DOI: 10.1074/jbc.M117.813139] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 5.4] [Reference Citation Analysis]
19 Pickering RJ, Tikellis C, Rosado CJ, Tsorotes D, Dimitropoulos A, Smith M, Huet O, Seeber RM, Abhayawardana R, Johnstone EK, Golledge J, Wang Y, Jandeleit-Dahm KA, Cooper ME, Pfleger KD, Thomas MC. Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis. J Clin Invest 2019;129:406-21. [PMID: 30530993 DOI: 10.1172/JCI99987] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
20 Mores KL, Cassell RJ, van Rijn RM. Arrestin recruitment and signaling by G protein-coupled receptor heteromers. Neuropharmacology 2019;152:15-21. [PMID: 30419245 DOI: 10.1016/j.neuropharm.2018.11.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
21 Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KD, Devi LA. G Protein-Coupled Receptor Heteromers. Annu Rev Pharmacol Toxicol 2016;56:403-25. [PMID: 26514203 DOI: 10.1146/annurev-pharmtox-011613-135952] [Cited by in Crossref: 168] [Cited by in F6Publishing: 140] [Article Influence: 24.0] [Reference Citation Analysis]
22 Cai X, Bai B, Zhang R, Wang C, Chen J. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling. Sci Rep 2017;7:40335. [PMID: 28091541 DOI: 10.1038/srep40335] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
23 Salazar N, Castellan M, Shirodkar SS, Lokeshwar BL. Chemokines and chemokine receptors as promoters of prostate cancer growth and progression. Crit Rev Eukaryot Gene Expr 2013;23:77-91. [PMID: 23557339 DOI: 10.1615/critreveukaryotgeneexpr.2013006905] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
24 Stephens B, Handel TM. Chemokine receptor oligomerization and allostery. Prog Mol Biol Transl Sci 2013;115:375-420. [PMID: 23415099 DOI: 10.1016/B978-0-12-394587-7.00009-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
25 Kocan M, Sarwar M, Hossain MA, Wade JD, Summers RJ. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3). Br J Pharmacol 2014;171:2827-41. [PMID: 24641548 DOI: 10.1111/bph.12623] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
26 Johnstone EKM, See HB, Abhayawardana RS, Song A, Rosengren KJ, Hill SJ, Pfleger KDG. Investigation of Receptor Heteromers Using NanoBRET Ligand Binding. Int J Mol Sci 2021;22:1082. [PMID: 33499147 DOI: 10.3390/ijms22031082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Tripathi A, Vana PG, Chavan TS, Brueggemann LI, Byron KL, Tarasova NI, Volkman BF, Gaponenko V, Majetschak M. Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function. Proc Natl Acad Sci U S A 2015;112:E1659-68. [PMID: 25775528 DOI: 10.1073/pnas.1417564112] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
28 Zamel IA, Palakkott A, Ashraf A, Iratni R, Ayoub MA. Interplay Between Angiotensin II Type 1 Receptor and Thrombin Receptor Revealed by Bioluminescence Resonance Energy Transfer Assay. Front Pharmacol 2020;11:1283. [PMID: 32973514 DOI: 10.3389/fphar.2020.01283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]